TSOI — Therapeutic Solutions International Cashflow Statement
0.000.00%
- $1.02m
- $2.28m
- $0.10m
Annual cashflow statement for Therapeutic Solutions International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.7 | -2.2 | -2.96 | -3.88 | -2.22 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.05 | 1.44 | 1.93 | 2.08 | 0.593 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.33 | 0.088 | 0.299 | 0.518 | 0.265 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -0.311 | -0.663 | -0.719 | -1.04 | -1.06 |
Capital Expenditures | — | -0.005 | -0.261 | 0 | -0.016 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | 0.004 | 0 | -0.008 |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | -0.005 | -0.257 | 0 | -0.024 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.315 | 0.894 | 0.817 | 0.943 | 1.08 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.004 | 0.226 | -0.158 | -0.095 | -0.002 |